Automating Assay Data Analysis Along the Antibody Discovery Pipeline

PEGS, Boston, Ma, USA
May 16, 2023

The discovery of antibody (Ab) therapeutics involves multiple stages from initial immunization or library screening through engineering and protein production, in which diverse assays are performed to test target binding affinity, protein expression and purity, cellular function, and beyond. Genedata Screener automates analysis of crucial common assays for antibody discovery and development. It reduces errors associated manual processing and copy-paste data transfer, thus increasing efficiency and ensuring higher result quality. Screener unifies analysis across the workflow and standardizes QC, harmonizing data between teams and facilitates result reporting and sharing. Screener is in productive use for Ab discovery workflows at leading biopharma organizations.